Q2 2017 13F Holders as of 30 Jun 2017
-
Type / Class
-
Equity / Ordinary shares, par value $0.0001 per share
-
Shares outstanding
-
1,385,160,313
-
Total 13F shares
-
20,400,002
-
Share change
-
+2,792,255
-
Total reported value
-
$917,998,000
-
Price per share
-
$45.00
-
Number of holders
-
57
-
Value change
-
+$131,190,803
-
Number of buys
-
33
-
Number of sells
-
26
Institutional Holders of BeOne Medicines Ltd. - Ordinary shares, par value $0.0001 per share (ONC) as of Q2 2017
As of 30 Jun 2017 BeOne Medicines Ltd. - Ordinary shares, par value $0.0001 per share (ONC) had 57 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 20,400,002 shares of stock of the company.
Largest 10 holders included FMR LLC, Hillhouse Capital Management, Ltd., BAKER BROS. ADVISORS LP, WELLINGTON MANAGEMENT GROUP LLP, ORBIMED ADVISORS LLC, PRICE T ROWE ASSOCIATES INC /MD/, OppenheimerFunds, Inc., Boxer Capital, LLC, BROWN ADVISORY INC, and Artal Group S.A..
This table shows 57 institutional shareholders of the security as of 30 Jun 2017.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.